PRAX insider buying and SEC filings, explained
Praxis Precision Medicines, Inc. · CIK 1689548
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$3.6M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 24, 2026 | Planned (10b5-1) | Jill DeSimone (Director) sold 11,600 shares at about $311.32 ($3.6M), marked as a 10b5-1 plan trade. Holdings down 83% to 2,337 shares. | SEC filing Filed Jun 26, 2026 |
36 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow PRAX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.